Related Experiment Video
Updated: Jul 7, 2025
14:20
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.7K
Autophagy-modulating biomembrane nanostructures: A robust anticancer weapon by modulating the inner and outer cancer
Xinyi Zhang1, Mengya Zhang2, Hengqing Cui3
1Institute of Translational Medicine, Shanghai University, Shanghai 200444, China; Changhai Clinical Research Unit, Shanghai Changhai Hospital, Naval Medical University, Shanghai 200433, China.
Summary
Biomembrane nanostructures show promise for cancer therapy, but resistance is an issue. Modulating autophagy with these nanostructures can enhance treatment effectiveness by influencing the tumor microenvironment and immune response.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Biology
Background:
- Biomembrane nanostructures (liposomes, exosomes) offer biocompatible anticancer therapies.
- Chemoresistance and radioresistance, linked to autophagy, limit their efficacy.
- Autophagy modulation is key to overcoming resistance and enhancing nanotherapy.
Purpose of the Study:
- To review the role of autophagy in cancer.
- To explore how autophagy modulation by biomembrane nanostructures enhances anticancer effects.
- To discuss clinical translation prospects and challenges.
Main Methods:
- Literature review of autophagy's role in cancer hallmarks.
- Analysis of studies combining biomembrane nanostructures with autophagy regulators.
- Examination of effects on cancer cells, immune cells, and the tumor microenvironment.
Main Results:
- Autophagy influences cancer progression, metastasis, immune response, and treatment resistance.
- Biomembrane nanostructures combined with autophagy modulation improve therapeutic sensitivity.
- Synergistic effects enhance drug accumulation and anti-tumor immune responses.
Conclusions:
- Autophagy modulation is a promising strategy to enhance biomembrane nanostructure-based cancer therapy.
- Understanding molecular mechanisms is crucial for developing effective nanotherapeutics.
- Further research is needed for successful clinical translation of these strategies.
Related Concept Videos
01:36Delivery Pathways to the Lysosome
6.6K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.6K
01:27Autophagy
4.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
01:15Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:46Electron Transport Chain: Complex I and II
13.7K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.7K
01:10Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K